In Vivo (Brooklyn). 2010;31(2):34-42.

Effects of Potential Therapeutic Agents on Copper Accumulations in Gill of Crassostrea virginica.

In vivo

Juan D Luxama, Margaret A Carroll, Edward J Catapane

PMID: 21841975 PMCID: PMC3154757

Abstract

Copper is an essential trace element for organisms, but when in excess, copper's redox potential enhances oxyradical formation and increases cellular oxidative stress. Copper is a major pollutant in Jamaica Bay and other aquatic areas. Bivalves are filter feeders that accumulate heavy metals and other pollutants from their environment. Previously it was determined that seed from the bivalve Crassostrea virginica, transplanted from an oyster farm to Jamaica Bay readily accumulated copper and other pollutants into their tissues. In the present study we utilized Atomic Absorption Spectrometry to measure the uptake of copper into C. virginica gill in the presence and absence of three potential copper -blocking agents: diltiazem, lanthanum, and p-aminosalicyclic acid. Diltiazem and lanthanum are known calcium-channel blockers and p-aminosalicylic acid is an anti-infammarory agent with possible metal chelating properties. We also used the DMAB-Rhodanine histochemistry staining technique to confirm that copper was entering gill cells. Our result showed that diltiazem and p-aminosalicyclic acid reduced copper accumulations in the gill, while lanthanum did not. DMAB-Rhodanine histochemistry showed enhanced cellular copper staining in copper-treated samples and further demonstrated that diltiazem was able to reduce copper uptake. The accumulation of copper into oyster gill and its potential toxic effects could be of physiological significance to the growth and long term health of oysters and other marine animals living in a copper polluted environment. Identifying agents that block cellular copper uptake will further the understanding of metal transport mechanisms and may be beneficial in the therapeutic treatment of copper toxicity in humans.

References

1. Int Rev Exp Pathol. 1990;31:165-88 - PubMed
2. Aquat Toxicol. 2000 Nov;51(1):115-38 - PubMed
3. In Vivo (Brooklyn). 2007 Fall;29(1):16-27 - PubMed
4. J Occup Environ Med. 2006 Jun;48(6):644-9 - PubMed
5. Brain. 1948 Dec;71(Pt. 4):410-5 - PubMed
6. Rev Physiol Biochem Pharmacol. 1990;114:1-105 - PubMed
7. J Environ Sci (China). 2001 Apr;13(2):210-7 - PubMed
8. Arch Pathol. 1969 Apr;87(4):370-9 - PubMed
9. Methods Enzymol. 1990;186:1-85 - PubMed
10. J Physiol. 1991 Sep;441:199-218 - PubMed
11. Biol Trace Elem Res. 1988 Dec;18:201-28 - PubMed
12. J Pharmacol Exp Ther. 1948 Apr;92(4):447-53 - PubMed
13. Arch Environ Contam Toxicol. 2003 Jul;45(1):92-101 - PubMed
14. Lancet. 2007 Feb 3;369(9559):397-408 - PubMed
15. J Gen Physiol. 1988 Apr;91(4):549-72 - PubMed
16. J Free Radic Biol Med. 1986;2(1):3-11 - PubMed
17. Circ Res. 1982 Nov;51(5):637-51 - PubMed
18. Lab Invest. 1956 May-Jun;5(3):299-305 - PubMed
19. Arch Pathol Lab Med. 1979 Aug;103(9):467-70 - PubMed
20. J Nutr. 1999 Jul;129(7):1251-60 - PubMed
21. Biochem J. 1984 Apr 1;219(1):1-14 - PubMed
22. Arch Environ Contam Toxicol. 1983 Jan;12(1):1-14 - PubMed
23. Biol Res. 2000;33(2):65-70 - PubMed
24. FEBS Lett. 1975 Jul 1;54(3):311-4 - PubMed
25. Comp Biochem Physiol C Toxicol Pharmacol. 2010 Mar;151(2):264-70 - PubMed
26. Neurotoxicology. 2009 Mar;30(2):240-8 - PubMed
27. Int J Tuberc Lung Dis. 2000 Sep;4(9):796-806 - PubMed
28. In Vivo (Brooklyn). 2005 Fall;27(1):15-26 - PubMed
29. J Chronic Dis. 1966 Sep;19(9):1007-34 - PubMed
30. Brain. 2009 Aug;132(Pt 8):1997-2001 - PubMed

Publication Types

• Journal Article

Grant support

• R25 GM062003/GM/NIGMS NIH HHS/United States
• R25 GM062003-09/GM/NIGMS NIH HHS/United States